Table 2.
Frequency of severe ADAMTS13 deficiency (activity < 10%) among patients for whom PEX treatment was requested for an initial clinical diagnosis of TTP or HUS: the Oklahoma TTP-HUS Registry experience, 1995-2011
View large
Frequency of severe ADAMTS13 deficiency (activity < 10%) among patients for whom PEX treatment was requested for an initial clinical diagnosis of TTP or HUS: the Oklahoma TTP-HUS Registry experience, 1995-2011

From November 13, 1995 through December 31, 2011, 301 (93%) of 333 consecutive patients enrolled in the Registry had ADAMTS13 activity measured in a sample obtained immediately before beginning the initial PEX by both FRETS and immunoblotting assays.3 

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal